Latest Biotech News

Researchers have developed a novel brain-computer interface that decodes imagined speech from motor cortex activity, enabling paralyzed patients to communicate by thinking words rather than...

A Phase I clinical trial demonstrated remarkable tumor regression in metastatic cancer patients using an Fc-optimized CD40 agonist antibody injected directly into tumors. Six out of twelve...

Scientists at UC San Diego identified a rapidly evolving human-accelerated region (HAR123) that functions as a transcriptional enhancer affecting genes involved in neural development and cognitive...

Syncell, a Taiwanese spatial proteomics company, has entered a co-marketing agreement with Thermo Fisher Scientific to integrate MicroScoop protein purification technology with Thermo Fisher’s...

Researchers at MIT have harnessed artificial intelligence to design novel antibiotics targeting drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). By...

The FDA faces scrutiny amid complex regulatory challenges highlighted by Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy safety concerns, including cases of acute liver failure...

Eli Lilly announced plans to increase drug list prices in Europe, including a triple price hike for its obesity drug Mounjaro in the UK, aiming to offset US pricing pressures linked to the Trump...

A first-in-human trial of an Fc-optimized CD40 agonistic antibody, 2141.V11, demonstrated promising systemic tumor regression in metastatic cancer patients. Delivered via intratumoral injection,...

Neuroscientists developed a brain-computer interface (BCI) capable of translating neural signals from the motor cortex associated with inner speech into real-time text. Tested on patients with...

Taiwanese spatial proteomics firm Syncell entered a co-marketing agreement with Thermo Fisher Scientific integrating Syncell’s Microscoop protein purification system with Thermo Fisher’s Orbitrap...

Innovations are emerging in targeted therapies for solid tumors including trispecific T-cell engager EVOLVE-104 from Evolveimmune with FDA IND clearance, and new antibody-drug conjugates targeting...

Machine learning and AI technologies are revolutionizing cancer diagnostics and drug discovery. Innovations include an AI-powered method for detecting ignition in inertial confinement fusion...

Researchers have achieved breakthroughs in battery materials and electrolytes, including the development of a quasi-solid 3D-SLISE electrolyte for lithium-ion batteries offering safety and...

Researchers at MIT have harnessed generative AI to design new antibiotic molecules effective against drug-resistant bacteria such as Neisseria gonorrhoeae and MRSA. The approach involved...

A clinical study from UCLA demonstrated that pembrolizumab, an immunotherapy targeting the PD-1 receptor, induced durable tumor regression in patients with unresectable desmoplastic melanoma, a...

Neuroscientists have unveiled a novel brain-computer interface allowing individuals with severe paralysis to communicate by decoding neural signals corresponding to inner speech. Unlike previous...

A first-in-human Phase I trial of an Fc-optimized CD40 agonistic antibody, 2141.V11, delivered intratumorally, has demonstrated preliminary clinical efficacy in metastatic cancer patients. Among...

Bayer and Kumquat Biosciences have entered an exclusive $1.3 billion collaboration to develop and commercialize inhibitors targeting the KRAS G12D mutation, a driver in multiple hard-to-treat...

The US government is withdrawing funding and partnerships supporting mRNA vaccine research for respiratory diseases, citing public trust issues. Despite mRNA vaccine technology’s success in...

Researchers at MIT have applied artificial intelligence to streamline the design of lipid nanoparticle (LNP) carriers for RNA vaccines and therapeutics. This work aims to overcome challenges in...